News | December 19, 2022
Stake sale in GMM Pfaudler by Pfaudler
Post the sale, Patel family has become the single largest promoter shareholder in the company
Post the sale, Patel family has become the single largest promoter shareholder in the company
China is now focusing on establishing volume and enhancing capabilities for innovative high value drug production
CINRYZE is plasma-derived C1-I NH approved for routine prevention (prophylaxis), short-term prevention or pre-procedure prevention, and acute attacks of HAE.
This is a phase two randomized, double-blind, parallel-group, placebo and active-controlled study
Empagliflozin is a novel sodium glucose co-transporter-2 (SGLT-2) inhibitor, which is useful for improving glycaemic control in adults with type-2 diabetes mellitus.
The MOU will involve product collaboration from both companies with a goal of propelling PFAS destruction in groundwater globally
Sanjeev is currently the Country President for AstraZeneca Malaysia
35 million mosquito nets supplied to countries in sub-Saharan Africa through partners
The company will set-up a pharmaceuticals formulation manufacturing unit with an investment of Rs. 100 crore in Odisha
Move to increase affordability and accessibility for heart failure patients across the country
Subscribe To Our Newsletter & Stay Updated
